Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinnan Li

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry|April 28, 2022
Design, synthesis and biological evaluation of hydrogen sulfide-releasing isochroman-4-one derivatives as new antihypertensive agent candidatesHongyu Wu, Xinnan Li, Chen He, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 3, 2024
Polyphenol nanocomplex modulates lactate metabolic reprogramming and elicits immune responses to enhance cancer therapeutic effectZhan Zhang, Xinnan Li, Weiqiang Liu, et al.
Frontiers in Immunology|December 19, 2022
Central nervous system tumefactive demyelinating lesions: Risk factors of relapse and follow-up observationsXinnan Li, Xiuling Miao, Yaming Wang, et al.
Annals of Palliative Medicine|November 11, 2022
Nalbuphine 20 mg combined with sufentanil 2 μg/kg exerts a better postoperative analgesia effect in patients undergoing a second cesarean section: a randomised trialJia Liu, Lungang Lin, Xinnan Li, et al.
Frontiers in Neurology|February 23, 2023
The value of convolutional neural networks-based deep learning model in differential diagnosis of space-occupying brain diseasesXiuling Miao, Tianyu Shao, Yaming Wang, et al.
The Journal of Clinical Investigation|November 28, 2023
TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalizationJingshu Tang, Yuying Kang, Yujun Zhou, et al.
Molecules (Basel, Switzerland)|May 28, 2022
Novel and Potent Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease from Natural (±)-7,8-Dihydroxy-3-methyl-isochroman-4-oneXinnan Li, Yilin Jia, Junda Li, et al.
European Journal of Medicinal Chemistry|April 28, 2020
Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitorsWen Shuai, Xinnan Li, Wenlong Li, et al.
European Journal of Medicinal Chemistry|January 1, 2026
A photoactivatable prodrug strategy toward spatially targeted inhibition of POLRMT for anticancer therapyLijuan Huang, Yunyue Wang, Minghui Yu, et al.
Bioorganic & Medicinal Chemistry|May 13, 2019
Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidatesShaowen Xie, Xinnan Li, Hao Yu, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|April 28, 2022
Design, synthesis and biological evaluation of hydrogen sulfide-releasing isochroman-4-one derivatives as new antihypertensive agent candidatesHongyu Wu, Xinnan Li, Chen He, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 3, 2024
Polyphenol nanocomplex modulates lactate metabolic reprogramming and elicits immune responses to enhance cancer therapeutic effectZhan Zhang, Xinnan Li, Weiqiang Liu, et al.
Frontiers in Immunology|December 19, 2022
Central nervous system tumefactive demyelinating lesions: Risk factors of relapse and follow-up observationsXinnan Li, Xiuling Miao, Yaming Wang, et al.
Annals of Palliative Medicine|November 11, 2022
Nalbuphine 20 mg combined with sufentanil 2 μg/kg exerts a better postoperative analgesia effect in patients undergoing a second cesarean section: a randomised trialJia Liu, Lungang Lin, Xinnan Li, et al.
Frontiers in Neurology|February 23, 2023
The value of convolutional neural networks-based deep learning model in differential diagnosis of space-occupying brain diseasesXiuling Miao, Tianyu Shao, Yaming Wang, et al.
The Journal of Clinical Investigation|November 28, 2023
TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalizationJingshu Tang, Yuying Kang, Yujun Zhou, et al.
Molecules (Basel, Switzerland)|May 28, 2022
Novel and Potent Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease from Natural (±)-7,8-Dihydroxy-3-methyl-isochroman-4-oneXinnan Li, Yilin Jia, Junda Li, et al.
European Journal of Medicinal Chemistry|April 28, 2020
Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitorsWen Shuai, Xinnan Li, Wenlong Li, et al.
European Journal of Medicinal Chemistry|January 1, 2026
A photoactivatable prodrug strategy toward spatially targeted inhibition of POLRMT for anticancer therapyLijuan Huang, Yunyue Wang, Minghui Yu, et al.
Bioorganic & Medicinal Chemistry|May 13, 2019
Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidatesShaowen Xie, Xinnan Li, Hao Yu, et al.
Pageof 8